Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Sill

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Acta Neuropathologica|September 30, 2023
Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristicsRamin Rahmanzade, Elke Pfaff, Rouzbeh Banan, et al.
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Nature Communications|November 24, 2023
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signaturesMelanie Schoof, Shweta Godbole, Thomas K Albert, et al.
Neuro-Oncology|November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFRPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Nature Communications|September 21, 2021
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/BMaximilian Y Deng, Dominik Sturm, Elke Pfaff, et al.
Acta Neuropathologica Communications|April 4, 2024
EpiDiP/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnosticsJürgen Hench, Claus Hultschig, Jon Brugger, et al.
Acta Neuropathologica|August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymomaDavid R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Nature Communications|June 16, 2025
Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomasRoland Imle, Daniel Blösel, Felix K F Kommoss, et al.
Cancer Communications (London, England)|March 15, 2025
Comprehensive DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature geneFlorian Henning Geyer, Alina Ritter, Seneca Kinn-Gurzo, et al.
Acta Neuropathologica|May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresMaximilian Y Deng, Martin Sill, Jason Chiang, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Acta Neuropathologica|September 30, 2023
Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristicsRamin Rahmanzade, Elke Pfaff, Rouzbeh Banan, et al.
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Nature Communications|November 24, 2023
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signaturesMelanie Schoof, Shweta Godbole, Thomas K Albert, et al.
Neuro-Oncology|November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFRPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Nature Communications|September 21, 2021
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/BMaximilian Y Deng, Dominik Sturm, Elke Pfaff, et al.
Acta Neuropathologica Communications|April 4, 2024
EpiDiP/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnosticsJürgen Hench, Claus Hultschig, Jon Brugger, et al.
Acta Neuropathologica|August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymomaDavid R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Nature Communications|June 16, 2025
Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomasRoland Imle, Daniel Blösel, Felix K F Kommoss, et al.
Cancer Communications (London, England)|March 15, 2025
Comprehensive DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature geneFlorian Henning Geyer, Alina Ritter, Seneca Kinn-Gurzo, et al.
Acta Neuropathologica|May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresMaximilian Y Deng, Martin Sill, Jason Chiang, et al.
Pageof 15